Cilli, A. Et Al. 2021. Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.. Pulmonary pharmacology & therapeutics , vol.71 , 102099.

Cilli, A., Uzer, F., Sevinç, C., Coşkun, F., Ursavaş, A., Öner, Ş., ... Kose, F.(2021). Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.. Pulmonary pharmacology & therapeutics , vol.71, 102099.

Cilli, Aykut Et Al. "Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.," Pulmonary pharmacology & therapeutics , vol.71, 102099, 2021

Cilli, Aykut Et Al. "Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.." Pulmonary pharmacology & therapeutics , vol.71, pp.102099, 2021

Cilli, A. Et Al. (2021) . "Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.." Pulmonary pharmacology & therapeutics , vol.71, p.102099.

@article{article, author={Aykut Cilli Et Al. }, title={Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.}, journal={Pulmonary pharmacology & therapeutics}, year=2021, pages={102099} }